Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$3.3M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 2 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 33 most recent Form 4 transactions.
| May 19 | KYMR | Kymera Therapeutics, Inc. | MEXER | 1,000 | $31.20 | $31.2K | — | Open the original filing on SEC.gov |
| Mar 20 | KYMR | Kymera Therapeutics, Inc. | MEXER◷◆ | 2,500 | — | — | — | Open the original filing on SEC.gov |
| Mar 20 | KYMR | Kymera Therapeutics, Inc. | SSELL◷ | 1,200 | $79.94 | $95.9K | -100.0% | Open the original filing on SEC.gov |
| Mar 20 | KYMR | Kymera Therapeutics, Inc. | SSELL◷ | 600 | $79.24 | $47.5K | -33.3% | Open the original filing on SEC.gov |
| Mar 20 | KYMR | Kymera Therapeutics, Inc. | SSELL◷ | 700 | $77.71 | $54.4K | -28.0% | Open the original filing on SEC.gov |
| Mar 20 | KYMR | Kymera Therapeutics, Inc. | MEXER◷ | 2,500 | $49.10 | $122.8K | — | Open the original filing on SEC.gov |
| Feb 20 | KYMR | Kymera Therapeutics, Inc. | MEXER◷◆ | 2,500 | — | — | — | Open the original filing on SEC.gov |
| Feb 20 | KYMR | Kymera Therapeutics, Inc. | SSELL◷ | 600 | $88.10 | $52.9K | -100.0% | Open the original filing on SEC.gov |
| Feb 20 | KYMR | Kymera Therapeutics, Inc. | SSELL◷ | 1,900 | $87.06 | $165.4K | -76.0% | Open the original filing on SEC.gov |
| Feb 20 | KYMR | Kymera Therapeutics, Inc. | MEXER◷ | 2,500 | $49.10 | $122.8K | — | Open the original filing on SEC.gov |
| Jan 20 | KYMR | Kymera Therapeutics, Inc. | MEXER◷◆ | 2,500 | — | — | — | Open the original filing on SEC.gov |
| Jan 20 | KYMR | Kymera Therapeutics, Inc. | MEXER◷◆ | 3,000 | — | — | — | Open the original filing on SEC.gov |
| Jan 20 | KYMR | Kymera Therapeutics, Inc. | SSELL◷ | 200 | $68.52 | $13.7K | -100.0% | Open the original filing on SEC.gov |
| Jan 20 | KYMR | Kymera Therapeutics, Inc. | SSELL◷ | 4,900 | $67.99 | $333.1K | -96.1% | Open the original filing on SEC.gov |
| Jan 20 | KYMR | Kymera Therapeutics, Inc. | SSELL◷ | 400 | $66.68 | $26.7K | -7.3% | Open the original filing on SEC.gov |
| Jan 20 | KYMR | Kymera Therapeutics, Inc. | MEXER◷ | 2,500 | $49.10 | $122.8K | +83.3% | Open the original filing on SEC.gov |
| Jan 20 | KYMR | Kymera Therapeutics, Inc. | MEXER◷ | 3,000 | $31.20 | $93.6K | — | Open the original filing on SEC.gov |
| Dec 17, 2025 | KYMR | Kymera Therapeutics, Inc. | MEXER◷◆ | 3,000 | — | — | — | Open the original filing on SEC.gov |
| Dec 17, 2025 | KYMR | Kymera Therapeutics, Inc. | MEXER◷◆ | 12,000 | — | — | — | Open the original filing on SEC.gov |
| Dec 17, 2025 | KYMR | Kymera Therapeutics, Inc. | MEXER◷◆ | 12,563 | — | — | — | Open the original filing on SEC.gov |
| Dec 17, 2025 | KYMR | Kymera Therapeutics, Inc. | SSELL◷ | 1,000 | $84.07 | $84.1K | -100.0% | Open the original filing on SEC.gov |
| Dec 17, 2025 | KYMR | Kymera Therapeutics, Inc. | SSELL◷ | 4,099 | $83.45 | $342.1K | -80.4% | Open the original filing on SEC.gov |
| Dec 17, 2025 | KYMR | Kymera Therapeutics, Inc. | SSELL◷ | 7,959 | $82.34 | $655.4K | -61.0% | Open the original filing on SEC.gov |
| Dec 17, 2025 | KYMR | Kymera Therapeutics, Inc. | SSELL◷ | 14,505 | $81.56 | $1.2M | -52.6% | Open the original filing on SEC.gov |
| Dec 17, 2025 | KYMR | Kymera Therapeutics, Inc. | MEXER◷ | 3,000 | $31.20 | $93.6K | +12.2% | Open the original filing on SEC.gov |
| Dec 17, 2025 | KYMR | Kymera Therapeutics, Inc. | MEXER◷ | 12,000 | $27.67 | $332K | +95.5% | Open the original filing on SEC.gov |
| Dec 17, 2025 | KYMR | Kymera Therapeutics, Inc. | MEXER◷ | 12,563 | $49.10 | $616.8K | — | Open the original filing on SEC.gov |
| Jun 25, 2025 | KYMR | Kymera Therapeutics, Inc. | AGRANT◆ | 16,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 3, 2025 | KYMR | Kymera Therapeutics, Inc. | MEXER◷◆ | 5,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 3, 2025 | KYMR | Kymera Therapeutics, Inc. | SSELL◷ | 5,000 | $49.04 | $245.2K | -100.0% | Open the original filing on SEC.gov |
| Jun 3, 2025 | KYMR | Kymera Therapeutics, Inc. | MEXER◷ | 5,000 | $29.55 | $147.8K | — | Open the original filing on SEC.gov |